The integrin/ILK/NF-κB [20], IGF1R/PI3K/AKT [21], and Wnt/β-catenin [22] pathways, as well as certain micro-RNAs have been proven to regulate or be regulated by IGFBP2 in a variety of malignant tumors. This evidence concerns the gene IGF1R and cancer.